The DOI matches its Crossref record; 132 of the 132 references it cites were found in a registry or an index.
Techniques of using circulating tumor DNA as a liquid biopsy component in cancer management
Open accessAbstract
Precision medicine in the clinical management of cancer may be achieved through the diagnostic platform called "liquid biopsy". This method utilizes the detection of biomarkers in blood for prognostic and predictive purposes. One of the latest blood born markers under investigation in the field of liquid biopsy in cancer patients is circulating tumor DNA (ctDNA). ctDNA is released by tumor cells through different mechanisms and can therefore provide information about the genomic make-up of the tumor currently present in the patient. Through longitudinal ctDNA-based liquid biopsies, tumor dynamics may be monitored to predict and assess drug response and/or resistance. However, because ctDNA is highly fragmented and because its concentration can be extremely low in a high background of normal circulating DNA, screening for clinical relevant mutations is challenging. Although significant progress has been made in advancing the detection and analysis of ctDNA in the last few years, the current challenges include standardization and increasing current techniques to single molecule sensitivity in combination with perfect specificity. This review focuses on the potential role of ctDNA in the clinical management of cancer patients, the current technologies that are being employed, and the hurdles that still need to be taken to achieve ctDNA-based liquid biopsy towards precision medicine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
STAR: ultrafast universal RNA-seq aligner
Dobin, A., Davis, C. A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M., & Gingeras, T. R. (2013) · Bioinformatics · doi:10.1093/bioinformatics/bts635 · Cited by 51,709
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data
McKenna, A., Hanna, M., Banks, E., Sivachenko, A., Cibulskis, K., Kernytsky, A., Garimella, K., Altshuler, D., Gabriel, S., Daly, M., et al. (2010) · Genome Research · doi:10.1101/gr.107524.110 · Cited by 27,895
Ultrafast and memory-efficient alignment of short DNA sequences to the human genome.
Langmead, B., Trapnell, C., Pop, M., & Salzberg, S. L. (2009) · Genome Biology · doi:10.1186/gb-2009-10-3-r25 · Cited by 21,849
Nishimura, R., Osako, T., Nishiyama, Y., Tashima, R., Nakano, M., Fujisue, M., Toyozumi, Y., & Arima, N. (2013) · Oncology · doi:10.1159/000353099 · Cited by 13,166
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
Bettegowda, C., Sausen, M., Leary, R. J., Kinde, I., Wang, Y., Agrawal, N., Bartlett, B. R., Wang, H., Luber, B., Alani, R. M., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007094 · Cited by 5,067
Haplotype-based variant detection from short-read sequencing
Garrison, E., & Marth, G. (2012) · arXiv · doi:10.48550/arxiv.1207.3907 · Cited by 3,700
Clonal heterogeneity and tumor evolution: past, present, and the future
McGranahan, N., & Swanton, C. (2017) · Cell · doi:10.1016/j.cell.2017.01.018 · Cited by 2,840
The molecular hallmarks of epigenetic control
Allis, C. D., & Jenuwein, T. (2016) · Nature Reviews Genetics · doi:10.1038/nrg.2016.59 · Cited by 2,809
Liquid biopsies come of age: Towards implementation of circulating tumour DNA
Wan, J. C. M., Massie, C., Garcia-Corbacho, J., Mouliere, F., Brenton, J. D., Caldas, C., Pacey, S., Baird, R., & Rosenfeld, N. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.7 · Cited by 2,809 · cited 3×
“The second mechanism of ctDNA release is by active secretion [23].”
BackgroundInfluentialCirculating mutant DNA to assess tumor dynamics
Diehl, F., Schmidt, K., Choti, M. A., Romans, K., Goodman, S., Li, M., Thornton, K., Agrawal, N., Sokoll, L., Szabo, S. A., et al. (2008) · Nature Medicine · doi:10.1038/nm.1789 · Cited by 2,734
An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage
Newman, A. M., Bratman, S. V., To, J., Wynne, J. F., Eclov, N. C. W., Modlin, L. A., Liu, C. L., Neal, J. W., Wakelee, H. A., Merritt, R. E., et al. (2014) · Nature Medicine · doi:10.1038/nm.3519 · Cited by 2,220
Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution
The TRACERx consortium, Abbosh, C., The PEACE consortium, Birkbak, N. J., Wilson, G. A., Jamal-Hanjani, M., Constantin, T., Salari, R., Le Quesne, J., Moore, D. A., et al. (2017) · Nature · doi:10.1038/nature22364 · Cited by 1,874
Thress, K. S., Paweletz, C. P., Felip, E., Cho, B. C., Stetson, D., Dougherty, B., Lai, Z., Markovets, A., Vivancos, A., Kuang, Y., et al. (2015) · Nature Medicine · doi:10.1038/nm.3854 · Cited by 1,589
BreakDancer: an algorithm for high-resolution mapping of genomic structural variation
Chen, K., Wallis, J. W., McLellan, M. D., Larson, D. E., Kalicki, J. M., Pohl, C. S., McGrath, S. D., Wendl, M. C., Zhang, Q., Locke, D. P., et al. (2009) · Nature Methods · doi:10.1038/nmeth.1363 · Cited by 1,479
Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis
Zhou, W., Fong, M. Y., Min, Y., Somlo, G., Liu, L., Palomares, M. R., Yu, Y., Chow, A., O’Connor, S. T. F., Chin, A. R., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.03.007 · Cited by 1,476
Cell-free DNA Comprises an In Vivo Nucleosome Footprint that Informs Its Tissues-Of-Origin
Snyder, M. W., Kircher, M., Hill, A. J., Daza, R. M., & Shendure, J. (2016) · Cell · doi:10.1016/j.cell.2015.11.050 · Cited by 1,464
Forshew, T., Murtaza, M., Parkinson, C., Gale, D., Tsui, D. W. Y., Kaper, F., Dawson, S.-J., Piskorz, A. M., Jimenez-Linan, M., Bentley, D., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003726 · Cited by 1,297
Dissecting the metastatic cascade
Pantel, K., & Brakenhoff, R. H. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1370 · Cited by 1,281
Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer
Garcia-Murillas, I., Schiavon, G., Weigelt, B., Ng, C., Hrebien, S., Cutts, R. J., Cheang, M., Osin, P., Nerurkar, A., Kozarewa, I., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aab0021 · Cited by 1,150
Detection and quantification of rare mutations with massively parallel sequencing
Kinde, I., Wu, J., Papadopoulos, N., Kinzler, K. W., & Vogelstein, B. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1105422108 · Cited by 1,144
Integrated digital error suppression for improved detection of circulating tumor DNA
Newman, A. M., Lovejoy, A. F., Klass, D. M., Kurtz, D. M., Chabon, J. J., Scherer, F., Stehr, H., Liu, C. L., Bratman, S. V., Say, C., et al. (2016) · Nature Biotechnology · doi:10.1038/nbt.3520 · Cited by 1,099
Circulating Tumor Cells in Patients with Breast Cancer Dormancy
Meng, S., Tripathy, D., Frenkel, E. P., Shete, S., Naftalis, E. Z., Huth, J. F., Beitsch, P. D., Leitch, M., Hoover, S., Euhus, D., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1110 · Cited by 971
The tumour-induced systemic environment as a critical regulator of cancer progression and metastasis
McAllister, S. S., & Weinberg, R. A. (2014) · Nature Cell Biology · doi:10.1038/ncb3015 · Cited by 966
Field guide to next‐generation DNA sequencers
GLENN, T. C. (2011) · Molecular Ecology Resources · doi:10.1111/j.1755-0998.2011.03024.x · Cited by 940
Best, M. G., Sol, N., Kooi, I., Tannous, J., Westerman, B. A., Rustenburg, F., Schellen, P., Verschueren, H., Post, E., Koster, J., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.09.018 · Cited by 916
Oxnard, G. R., Thress, K. S., Alden, R. S., Lawrance, R., Paweletz, C. P., Cantarini, M., Yang, J. C.-H., Barrett, J. C., & Jänne, P. A. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.66.7162 · Cited by 850
Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients
Jiang, P., Chan, C. W. M., Chan, K. C. A., Cheng, S. H., Wong, J., Wong, V. W.-S., Wong, G. L. H., Chan, S. L., Mok, T. S. K., Chan, H. L. Y., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1500076112 · Cited by 738
Plasma ESR1 Mutations and the Treatment of Estrogen Receptor–Positive Advanced Breast Cancer
Fribbens, C., O’Leary, B., Kilburn, L., Hrebien, S., Garcia-Murillas, I., Beaney, M., Cristofanilli, M., Andre, F., Loi, S., Loibl, S., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.67.3061 · Cited by 722
DNA Methylation Analysis: Choosing the Right Method
Kurdyukov, S., & Bullock, M. (2016) · Biology · doi:10.3390/biology5010003 · Cited by 705
Lanman, R. B., Mortimer, S. A., Zill, O. A., Sebisanovic, D., Lopez, R., Blau, S., Collisson, E. A., Divers, S. G., Hoon, D. S. B., Kopetz, E. S., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0140712 · Cited by 695 · cited 1×
“01–90% of the total cell-free DNA (cfDNA) found in blood [27,28].”
BackgroundClinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA
Thierry, A. R., Mouliere, F., El Messaoudi, S., Mollevi, C., Lopez-Crapez, E., Rolet, F., Gillet, B., Gongora, C., Dechelotte, P., Robert, B., et al. (2014) · Nature Medicine · doi:10.1038/nm.3511 · Cited by 678
Chabon, J. J., Simmons, A. D., Lovejoy, A. F., Esfahani, M. S., Newman, A. M., Haringsma, H. J., Kurtz, D. M., Stehr, H., Scherer, F., Karlovich, C. A., et al. (2016) · Nature Communications · doi:10.1038/ncomms11815 · Cited by 648
Tie, J., Kinde, I., Wang, Y., Wong, H. L., Roebert, J., Christie, M., Tacey, M., Wong, R., Singh, M., Karapetis, C. S., et al. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv177 · Cited by 635
Quantification of Free Circulating DNA As a Diagnostic Marker in Lung Cancer
Sozzi, G., Conte, D., Leon, M., Cirincione, R., Roz, L., Ratcliffe, C., Roz, E., Cirenei, N., Bellomi, M., Pelosi, G., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.02.006 · Cited by 552
Biology, detection, and clinical implications of circulating tumor cells
Joosse, S. A., Gorges, T. M., & Pantel, K. (2015) · EMBO Molecular Medicine · doi:10.15252/emmm.201303698 · Cited by 528
Self-citationOncogenes and Tumor Suppressor Genes
Lee, E. Y. H. P., & Muller, W. J. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a003236 · Cited by 508
Detecting ultralow-frequency mutations by Duplex Sequencing
Kennedy, S. R., Schmitt, M. W., Fox, E. J., Kohrn, B. F., Salk, J. J., Ahn, E. H., Prindle, M. J., Kuong, K. J., Shen, J.-C., Risques, R.-A., et al. (2014) · Nature Protocols · doi:10.1038/nprot.2014.170 · Cited by 503 · cited 1×
“These extreme low concentrations make the detection challenging, particularly at the early stages of tumor development [27,73,74].”
BackgroundThress, K. S., Brant, R., Carr, T. H., Dearden, S., Jenkins, S., Brown, H., Hammett, T., Cantarini, M., & Barrett, J. C. (2015) · Lung Cancer · doi:10.1016/j.lungcan.2015.10.004 · Cited by 493
Taly, V., Pekin, D., Benhaim, L., Kotsopoulos, S. K., Le Corre, D., Li, X., Atochin, I., Link, D. R., Griffiths, A. D., Pallier, K., et al. (2013) · Clinical Chemistry · doi:10.1373/clinchem.2013.206359 · Cited by 492
Circulating Tumor Cells and Circulating Tumor DNA
Alix-Panabières, C., Schwarzenbach, H., & Pantel, K. (2012) · Annual Review of Medicine · doi:10.1146/annurev-med-062310-094219 · Cited by 485
Liquid Biopsies, What We Do Not Know (Yet)
Bardelli, A., & Pantel, K. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.01.002 · Cited by 482
Standards and Guidelines for Validating Next-Generation Sequencing Bioinformatics Pipelines
Roy, S., Coldren, C., Karunamurthy, A., Kip, N. S., Klee, E. W., Lincoln, S. E., Leon, A., Pullambhatla, M., Temple-Smolkin, R. L., Voelkerding, K. V., et al. (2018) · The Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2017.11.003 · Cited by 469
Olsson, E., Winter, C., George, A., Chen, Y., Howlin, J., Tang, M. E., Dahlgren, M., Schulz, R., Grabau, D., van Westen, D., et al. (2015) · EMBO Molecular Medicine · doi:10.15252/emmm.201404913 · Cited by 453
Sozzi, G., Conte, D., Mariani, L., Vullo, S. L., Roz, L., Lombardo, C., Pierotti, M. A., & Tavecchio, L. (2001) · PubMed · Cited by 421
Tumor Heterogeneity and Lesion-Specific Response to Targeted Therapy in Colorectal Cancer
Russo, M., Siravegna, G., Blaszkowsky, L. S., Corti, G., Crisafulli, G., Ahronian, L. G., Mussolin, B., Kwak, E. L., Buscarino, M., Lazzari, L., et al. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-1283 · Cited by 405
Detection of Cancer DNA in Plasma of Patients with Early-Stage Breast Cancer
Beaver, J. A., Jelovac, D., Balukrishna, S., Cochran, R. L., Croessmann, S., Zabransky, D. J., Wong, H. Y., Valda Toro, P., Cidado, J., Blair, B. G., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2933 · Cited by 398
Hemodynamic Forces Tune the Arrest, Adhesion, and Extravasation of Circulating Tumor Cells
Follain, G., Osmani, N., Azevedo, A. S., Allio, G., Mercier, L., Karreman, M. A., Solecki, G., Garcia Leòn, M. J., Lefebvre, O., Fekonja, N., et al. (2018) · Developmental Cell · doi:10.1016/j.devcel.2018.02.015 · Cited by 343
Quantitative Detection of EGFR Mutations in Circulating Tumor DNA Derived from Lung Adenocarcinomas
Taniguchi, K., Uchida, J., Nishino, K., Kumagai, T., Okuyama, T., Okami, J., Higashiyama, M., Kodama, K., Imamura, F., & Kato, K. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1712 · Cited by 315
Detection of Tumor PIK3CA Status in Metastatic Breast Cancer Using Peripheral Blood
Higgins, M. J., Jelovac, D., Barnathan, E., Blair, B., Slater, S., Powers, P., Zorzi, J., Jeter, S. C., Oliver, G. R., Fetting, J., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2696 · Cited by 309
Genetic and epigenetic alterations as biomarkers for cancer detection, diagnosis and prognosis
Herceg, Z., & Hainaut, P. (2007) · Molecular Oncology · doi:10.1016/j.molonc.2007.01.004 · Cited by 282
An integrative variant analysis suite for whole exome next-generation sequencing data
Challis, D., Yu, J., Evani, U. S., Jackson, A. R., Paithankar, S., Coarfa, C., Milosavljevic, A., Gibbs, R. A., & Yu, F. (2012) · BMC Bioinformatics · doi:10.1186/1471-2105-13-8 · Cited by 269
García-Olmo, D. C., Domínguez, C., García-Arranz, M., Anker, P., Stroun, M., García-Verdugo, J. M., & García-Olmo, D. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3513 · Cited by 267
Gifford, G., Paul, J., Vasey, P. A., Kaye, S. B., Brown, R., & on behalf of the Scottish Gynaecological Clinical Trials Group (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0732 · Cited by 262
BEAMing up for detection and quantification of rare sequence variants
Li, M., Diehl, F., Dressman, D., Vogelstein, B., & Kinzler, K. W. (2006) · Nature Methods · doi:10.1038/nmeth850 · Cited by 261
Paweletz, C. P., Sacher, A. G., Raymond, C. K., Alden, R. S., O'Connell, A., Mach, S. L., Kuang, Y., Gandhi, L., Kirschmeier, P., English, J. M., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1627-t · Cited by 244
Amplification‐Refractory Mutation System (ARMS) Analysis of Point Mutations
Little, S. (1995) · Current Protocols in Human Genetics · doi:10.1002/0471142905.hg0908s07 · Cited by 243
Yu, S. C., Lee, S. W., Jiang, P., Leung, T. Y., Chan, K. A., Chiu, R. W., & Lo, Y. D. (2013) · Clinical Chemistry · doi:10.1373/clinchem.2013.203679 · Cited by 242
Cell-free DNA: measurement in various carcinomas and establishment of normal reference range
Wu, T.-L., Zhang, D., Chia, J.-H., Tsao, K.-C., Sun, C.-F., & Wu, J. T. (2002) · Clinica Chimica Acta · doi:10.1016/s0009-8981(02)00091-8 · Cited by 232
Genomic and Epigenomic Alterations in Cancer
Chakravarthi, B. V. S. K., Nepal, S., & Varambally, S. (2016) · The American Journal of Pathology · doi:10.1016/j.ajpath.2016.02.023 · Cited by 223
Couraud, S., Vaca-Paniagua, F., Villar, S., Oliver, J., Schuster, T., Blanché, H., Girard, N., Trédaniel, J., Guilleminault, L., Gervais, R., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-3063 · Cited by 215
Kristensen, L. S., & Hansen, L. L. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2008.121962 · Cited by 212
A Comparison of Cell-Free DNA Isolation Kits
Sorber, L., Zwaenepoel, K., Deschoolmeester, V., Roeyen, G., Lardon, F., Rolfo, C., & Pauwels, P. (2017) · The Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2016.09.009 · Cited by 207
Song, L., Jia, J., Peng, X., Xiao, W., & Li, Y. (2017) · Scientific Reports · doi:10.1038/s41598-017-03321-8 · Cited by 207
Choi, J., Reich, C. F., & Pisetsky, D. S. (2005) · Immunology · doi:10.1111/j.1365-2567.2005.02130.x · Cited by 198
Bao, R., Huang, L., Andrade, J., Tan, W., Kibbe, W. A., Jiang, H., & Feng, G. (2014) · Cancer Informatics · doi:10.4137/cin.s13779 · Cited by 197
Tumor Evolution as a Therapeutic Target
Amirouchene-Angelozzi, N., Swanton, C., & Bardelli, A. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-0343 · Cited by 194
Detection and Monitoring of Cell‐Free DNA in Blood of Patients with Colorectal Cancer
Schwarzenbach, H., Stoehlmacher, J., Pantel, K., & Goekkurt, E. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1448.025 · Cited by 193
Identification of Circulating Tumor DNA for the Early Detection of Small-cell Lung Cancer
Fernandez-Cuesta, L., Perdomo, S., Avogbe, P. H., Leblay, N., Delhomme, T. M., Gaborieau, V., Abedi-Ardekani, B., Chanudet, E., Olivier, M., Zaridze, D., et al. (2016) · eBioMedicine · doi:10.1016/j.ebiom.2016.06.032 · Cited by 193
Establishment of tumor‐specific copy number alterations from plasma DNA of patients with cancer
Heitzer, E., Auer, M., Hoffmann, E. M., Pichler, M., Gasch, C., Ulz, P., Lax, S., Waldispuehl‐Geigl, J., Mauermann, O., Mohan, S., et al. (2013) · International Journal of Cancer · doi:10.1002/ijc.28030 · Cited by 175
Gale, D., Lawson, A. R. J., Howarth, K., Madi, M., Durham, B., Smalley, S., Calaway, J., Blais, S., Jones, G., Clark, J., et al. (2018) · PLOS ONE · doi:10.1371/journal.pone.0194630 · Cited by 172
Mastoraki, S., Strati, A. D., Tzanikou, E., Chimonidou, M., Politaki, E., Voutsina, A., Psyrri, A. K., Georgoulias, V., & Lianidou, E. S. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-1181 · Cited by 168
The potential of liquid biopsies for the early detection of cancer
Heitzer, E., Perakis, S., Geigl, J. B., & Speicher, M. R. (2017) · npj Precision Oncology · doi:10.1038/s41698-017-0039-5 · Cited by 166
Narayan, A., Carriero, N. J., Gettinger, S. N., Kluytenaar, J., Kozak, K. R., Yock, T. I., Muscato, N. E., Ugarelli, P., Decker, R. H., & Patel, A. A. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-4037 · Cited by 165
Guttery, D. S., Page, K., Hills, A., Woodley, L., Marchese, S. D., Rghebi, B., Hastings, R. K., Luo, J., Pringle, J. H., Stebbing, J., et al. (2015) · Clinical Chemistry · doi:10.1373/clinchem.2015.238717 · Cited by 164
Tumor-Educated Platelets as Liquid Biopsy in Cancer Patients
Joosse, S. A., & Pantel, K. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.10.007 · Cited by 161
Self-citationKoo, K. M., Carrascosa, L. G., Shiddiky, M. J. A., & Trau, M. (2016) · Analytical Chemistry · doi:10.1021/acs.analchem.5b04795 · Cited by 161
Joosse, S. A., Hannemann, J., Spötter, J., Bauche, A., Andreas, A., Müller, V., & Pantel, K. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2100 · Cited by 155
Self-citationPIK3CA mutations in serum DNA are predictive of recurrence in primary breast cancer patients
Oshiro, C., Kagara, N., Naoi, Y., Shimoda, M., Shimomura, A., Maruyama, N., Shimazu, K., Kim, S. J., & Noguchi, S. (2015) · Breast Cancer Research and Treatment · doi:10.1007/s10549-015-3322-6 · Cited by 151
Wen, L., Li, J., Guo, H., Liu, X., Zheng, S., Zhang, D., Zhu, W., Qu, J., Guo, L., Du, D., et al. (2015) · Cell Research · doi:10.1038/cr.2015.126 · Cited by 148
Pérez-Barrios, C., Nieto-Alcolado, I., Torrente, M., Jiménez‐Sánchez, C., Calvo, V., Gutiérrez-Sanz, L., Palka, M., Donoso-Navarro, E., Provencio, M., & Romero, A. (2016) · Translational Lung Cancer Research · doi:10.21037/tlcr.2016.12.03 · Cited by 145
Cancer Progression Mediated by Horizontal Gene Transfer in an In Vivo Model
Trejo‐Becerril, C., Pérez‐Cárdenas, E., Taja‐Chayeb, L., Anker, P., Herrera‐Goepfert, R., Medina-Velázquez, L. A., Hidalgo‐Miranda, A., Pérez‐Montiel, D., Chávez-Blanco, A. D., Cruz, J., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052754 · Cited by 134
Comparison of Circulating Plasma DNA Levels between Lung Cancer Patients and Healthy Controls
Yoon, K., Park, S., Lee, S., Kim, J. H., & Lee, J. S. (2009) · Journal of Molecular Diagnostics · doi:10.2353/jmoldx.2009.080098 · Cited by 121
Wee, E. J. H., Wang, Y., Tsao, S. C., & Trau, M. (2016) · Theranostics · doi:10.7150/thno.15871 · Cited by 119
Belic, J., Koch, M., Ulz, P., Auer, M., Gerhalter, T., Mohan, S., Fischereder, K., Petru, E., Bauernhofer, T., Geigl, J. B., et al. (2015) · Clinical Chemistry · doi:10.1373/clinchem.2014.234286 · Cited by 117
Recent developments and future directions in SERS for bioanalysis
Harper, M. M., McKeating, K. S., & Faulds, K. (2013) · Physical Chemistry Chemical Physics · doi:10.1039/c2cp43859c · Cited by 117
Uchida, J., Kato, K., Kukita, Y., Kumagai, T., Nishino, K., Daga, H., Nagatomo, I., Inoue, T., Kimura, M., Oba, S., et al. (2015) · Clinical Chemistry · doi:10.1373/clinchem.2015.241414 · Cited by 117
Freidin, M. B., Freydin, M., Leung, M., Montero, Á., Nicholson, A. G., & Lim, E. K. S. (2015) · Clinical Chemistry · doi:10.1373/clinchem.2015.242453 · Cited by 116
Wang, W. T., Kong, P., Ma, G., Li, L., Zhu, J., Xia, T., Xie, H., Zhou, W., & Wang, S. (2017) · Oncotarget · doi:10.18632/oncotarget.17858 · Cited by 114
Quantitative Analysis of Circulating Plasma DNA as a Tumor Marker in Thoracic Malignancies
Herrera, L. J., Raja, S., Gooding, W. E., El‐Hefnawy, T., Kelly, L. A., Luketich, J. D., & Godfrey, T. E. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2004.039263 · Cited by 111
Detection of EGFR mutations in circulating free DNA by PNA-mediated PCR clamping
Kim, H.-R., Lee, S. Y., Hyun, D.-S., Lee, M. K., Lee, H.-K., Choi, C., Yang, S. H., Kim, Y., Lee, Y. C., Kim, S. Y., et al. (2013) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-32-50 · Cited by 109
Platelet RNA signatures for the detection of cancer
Sol, N., & Würdinger, T. (2017) · Cancer and Metastasis Reviews · doi:10.1007/s10555-017-9674-0 · Cited by 108
Cancer bioinformatics: A new approach to systems clinical medicine
Wu, D., Rice, C. M., & Wang, X. (2012) · BMC Bioinformatics · doi:10.1186/1471-2105-13-71 · Cited by 106
Extracellular vesicles for liquid biopsy in prostate cancer: where are we and where are we headed?
Minciacchi, V. R., Zijlstra, A., Rubin, M. A., & Vizio, D. D. (2017) · Prostate Cancer and Prostatic Diseases · doi:10.1038/pcan.2017.7 · Cited by 94
Chen, J., Zhang, D., Yan, W., Yang, D., & Shen, B. (2013) · BioMed Research International · doi:10.1155/2013/901578 · Cited by 87
Genomewide bisulfite sequencing reveals the origin and time-dependent fragmentation of urinary cfDNA
Cheng, T. H. T., Jiang, P., Tam, J. C. W., Sun, X., Lee, W., Yu, S. C. Y., Teoh, J. Y., Chiu, P. K., Ng, C., Chow, K. M., et al. (2017) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2017.02.017 · Cited by 82
Ultrasensitive Detection of Multiplexed Somatic Mutations Using MALDI-TOF Mass Spectrometry
Mosko, M., Nakorchevsky, A., Flores, E., Metzler, H., Ehrich, M., van den Boom, D., Sherwood, J. L., & Nygren, A. O. H. (2015) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2015.08.001 · Cited by 81
Miyazawa, H., Tanaka, T., Nagai, Y., Matsuoka, M., Huqun, Sutani, A., Udagawa, K., Zhang, J., Hirama, T., Murayama, Y., et al. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2007.00706.x · Cited by 79
Kloten, V., Rüchel, N., Brüchle, N. O., Gasthaus, J., Freudenmacher, N., Steib, F., Mijnes, J., Eschenbruch, J., Binnebösel, M., Knüchel, R., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.21134 · Cited by 78
Sefrioui, D., Sarafan‐Vasseur, N., Beaussire, L., Baretti, M., Gangloff, A., Blanchard, F., Clatot, F., Sabourin, J., Sesboüé, R., Frébourg, T., et al. (2015) · Digestive and Liver Disease · doi:10.1016/j.dld.2015.05.023 · Cited by 77
Czeiger, D., Shaked, G., Eini, H., Vered, I., Belochitski, O., Avriel, A., Ariad, S., & Douvdevani, A. (2011) · American Journal of Clinical Pathology · doi:10.1309/ajcp4rk2ihvkttzv · Cited by 77
Veldore, V. H., Choughule, A. B., Routhu, T., Mandloi, N., Noronha, V., Joshi, A., Dutt, A., Gupta, R. K., Ramprasad, V. L., & Prabhash, K. (2018) · Lung Cancer Targets and Therapy · doi:10.2147/lctt.s147841 · Cited by 74
Kuo, Y., Chen, J., Fan, C., Li, Y.-S., & Chan, E. (2014) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.03.024 · Cited by 73
Circulating DNA: Diagnostic Tool and Predictive Marker for Overall Survival of NSCLC Patients
Catarino, R., Coelho, A., Araújo, A., Gomes, M. P., Nogueira, A., Lopes, C., & Medeiros, R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038559 · Cited by 70
Fong, S. L., Zhang, J. T., Lim, C. K., et al. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2008.110122 · Cited by 70
Kinde, I., Papadopoulos, N., Kinzler, K. W., & Vogelstein, B. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041162 · Cited by 69
Koçkan, C., Hach, F., Sarrafi, I., Bell, R. H., McConeghy, B. J., Beja, K., Haegert, A. M., Wyatt, A. W., Volik, S. V., Chi, K. N., et al. (2016) · Bioinformatics · doi:10.1093/bioinformatics/btw536 · Cited by 69
Exercise is a potent stimulus for enhancing circulating DNase activity
Velders, M., Treff, G., Machus, K., Bosnyák, E., Steinacker, J. M., & Schümann, U. (2014) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2013.12.017 · Cited by 67
Improved Method for Isolating Cell-Free DNA
Schmidt, B., Weickmann, S., Witt, C. C., & Fleischhacker, M. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2005.051003 · Cited by 63
Quantitative analysis of cell-free DNA in ovarian cancer
Shao, X.-F., He, Y., JI, M., Chen, X., Qi, J., Shi, W., HAO, T., & Ju, S. (2015) · Oncology Letters · doi:10.3892/ol.2015.3771 · Cited by 61
Predicting the sensitivity and specificity of published real-time PCR assays
Lemmon, G., & Gardner, S. N. (2008) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/1476-0711-7-18 · Cited by 61
Espósito, A., Criscitiello, C., Trapani, D., & Curigliano, G. (2017) · Current Oncology Reports · doi:10.1007/s11912-017-0564-y · Cited by 61
Quantity versus quality: Optimal methods for cell-free DNA isolation from plasma of pregnant women
Jorgez, C. J., Dang, D., Simpson, J. L., Lewis, D. E., & Bischoff, F. Z. (2006) · Genetics in Medicine · doi:10.1097/01.gim.0000241904.32039.6f · Cited by 60
Blood-Based Analysis of Circulating Cell-Free DNA and Tumor Cells for Early Cancer Detection
Pantel, K. (2016) · PLoS Medicine · doi:10.1371/journal.pmed.1002205 · Cited by 56
Wong, S. Q., FELLOWES, A. P., Doig, K. M., Ellul, J., Bosma, T. J., Irwin, D. E., Vedururu, R., Tan, A., Weiss, J. M., Chan, K. S., et al. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.80 · Cited by 52
Kirsch, C., Weickmann, S., Schmidt, B., & Fleischhacker, M. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1448.035 · Cited by 50
Song, L., Yu, H., Jia, J., & Li, Y. (2017) · Cancer Biomarkers · doi:10.3233/cbm-160321 · Cited by 50
Circulating Tumor Cells Revisited
Cristofanilli, M. (2010) · JAMA · doi:10.1001/jama.2010.292 · Cited by 47
The Cobas ® EGFR Mutation Test v2 Assay
Brown, P. (2016) · Future Oncology · doi:10.2217/fon.15.311 · Cited by 47
Müller, I., Beeger, C., Alix‐Panabières, C., Rébillard, X., Pantel, K., & Schwarzenbach, H. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2007.099333 · Cited by 45
Detection of KIT and PDGFRA mutations in the plasma of patients with gastrointestinal stromal tumor
Kang, G., Bae, B. N., Sohn, B. S., Pyo, J., Kang, G. H., & Kim, K. (2015) · Targeted Oncology · doi:10.1007/s11523-015-0361-1 · Cited by 41
Wang, H., Jiang, J., Mostert, B., Sieuwerts, A. M., Martens, J. W. M., Sleijfer, S., Foekens, J. A., & Wang, Y. (2012) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2012.08.007 · Cited by 40
Lee, H., Jeon, S., Seo, J.-S., Goh, S., Han, J., & Cho, Y. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.06.003 · Cited by 39
EGFR Mutation Analysis of Circulating Tumor DNA Using an Improved PNA-LNA PCR Clamp Method
Watanabe, K., Fukuhara, T., Tsukita, Y., Morita, M., Suzuki, A. S., Tanaka, N., Terasaki, H., Nukiwa, T., & Maemondo, M. (2016) · Canadian Respiratory Journal · doi:10.1155/2016/5297329 · Cited by 39
mFast-SeqS as a Monitoring and Pre-screening Tool for Tumor-Specific Aneuploidy in Plasma DNA
Belic, J., Koch, M., Ulz, P., Auer, M., Gerhalter, T., Mohan, S., Fischereder, K., Petru, E., Bauernhofer, T., Geigl, J. B., et al. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-42044-8_28 · Cited by 38
Biology and clinical significance of circulating tumor cell subpopulations in lung cancer
O′Flaherty, L., Wikman, H., & Pantel, K. (2017) · Translational Lung Cancer Research · doi:10.21037/tlcr.2017.07.03 · Cited by 37
Cell-free DNA in non-small cell lung cancer
Gedvilaitė, V., Schveigert, D., & Cicėnas, S. (2017) · Acta medica Lituanica · doi:10.6001/actamedica.v24i2.3495 · Cited by 30
Tseng, J.-Y., Yang, C., Liang, S.-C., Liu, R.-S., Jiang, J., & Lin, C.-H. (2014) · Cancers · doi:10.3390/cancers6042369 · Cited by 29
Genetic traits for hematogeneous tumor cell dissemination in cancer patients
Joosse, S. A., & Pantel, K. (2016) · Cancer and Metastasis Reviews · doi:10.1007/s10555-016-9611-7 · Cited by 28
Self-citationDetection and Quantification of KIT Mutations in ctDNA by Plasma Safe-SeqS
Fredebohm, J., Mehnert, D. H., Löber, A.-K., Holtrup, F., van Rahden, V. A., Angenendt, P., & Diehl, F. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-42044-8_34 · Cited by 22
Cell‐free fetal DNA ‐based noninvasive prenatal testing of aneuploidy
Mackie, F. L., Allen, S. K., Morris, R. K., & Kilby, M. D. (2017) · The Obstetrician & Gynaecologist · doi:10.1111/tog.12388 · Cited by 15
Cited by
DNA Methylation Cancer Biomarkers: Translation to the Clinic
Locke, W. J., Guanzon, D., Ma, C., Liew, Y. J., Duesing, K. R., Fung, K. Y. C., & Ross, J. P. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.01150 · Cited by 472
Clinical relevance of blood-based ctDNA analysis: mutation detection and beyond
Keller, L., Belloum, Y., Wikman, H., & Pantel, K. (2021) · British Journal of Cancer · doi:10.1038/s41416-020-01047-5 · Cited by 401
Extracellular vesicles as biomarkers and therapeutic targets for cancer
Urabe, F., Kosaka, N., Ito, K., Kimura, T., Egawa, S., & Ochiya, T. (2020) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00280.2019 · Cited by 397
Liquid Biopsy of Methylation Biomarkers in Cell-Free DNA
Luo, H., Wei, W., Ye, Z., Zheng, J., & Xu, R.-H. (2021) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2020.12.011 · Cited by 319
ctDNA as a cancer biomarker: A broad overview
Pessoa, L. S., Heringer, M., & Ferrer, V. P. (2020) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2020.103109 · Cited by 298
Metadata
- Authors
- Elazezy, M., & Joosse, S. A.
- Venue
- Computational and Structural Biotechnology Journal
- Published
- 2018
- Volume
- 16
- Pages
- 370-378
- ISSN
- 2001-0370 (ISSN-L)
- OpenAlex
- W2897483101
- Cited by
- 370
- References
- 132
- FWCI
- 10.84
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.